non-fatal myocardial infarction, sustained estimated glomerular filtration rate (eGFR) decline, and end-stage kidney disease.

Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor was associated with lower rates of ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

In recent months, Karnataka has witnessed a disturbing rise in sudden cardiac deaths among young individuals—many of them ...

The recent surge in sudden deaths and collapses has sparked widespread concern, with many questioning the underlying causes. Reports of individuals collapsing without warning have become increasingly ...

While heart conditions aren’t uncommon among hockey players, New York State currently does not mandate cardiac screening for high school athletes.

A STEMI heart attack is the most serious kind because one of the heart’s main supply arteries is completely blocked. After ...

In acute myocardial infarction (AMI) survivors younger than the age of 65, living in a marginalized neighbourhood was ...

Background The burden of cardiovascular events in Africa is projected to rise significantly in the coming decade, placing ...

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Patients with overweight or obesity and heart failure with preserved ejection fraction that have unintentional weight loss have worse outcomes.